Spyre Therapeutics SYRE Valuation Ratios and Share Stats

Gold vs US Dollar

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Spyre Therapeutics Inc (SYRE)
Spyre Therapeutics Inc (SYRE) Financials

Statistics

Annual Quarterly

Year End 31 December 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-44.236	-66.282	-97.257	-66.089	-48.464	-92.577	-164.062	-43.777
Return on Equity (%)	-48.076	-75.316	-122.743	-80.928	-58.81	-124.868	-289.167	-59.28
Return on Invested Capital (%)	-48.971	-77.395	-127.536	-82.895	-59.792	-130.079	-163.595	-53.081
Operating Margin (%)	-523.266	-1140.638	N/A	N/A	-350.392	-3604.594	-38241.084	N/A
Net Profit Margin (%)	-523.266	-1140.638	N/A	N/A	-351.145	-3598.755	-38238.149	N/A
Book Value Per Share	1.963	2.036	1.579	2.456	1.439	0.714	20.624	8.471
Earnings Per Share	-1.062	-1.339	-2.056	-1.421	-1.128	-1.189	-26.017	-3.403
Cash Per Share	0.5	0.678	0.506	1.583	0.26	0.495	14.506	1.463
Working Capital Per Share	1.925	2.006	1.475	2.342	1.35	0.675	23.771	9.069
Operating Profit Per Share	0.203	0.117	N/A	N/A	0.321	0.033	0.068	N/A
EBIT Per Share	-1.062	-1.339	-2.056	-1.421	-1.126	-1.191	-26.019	-3.402
EBITDA Per Share	-1.062	-1.339	-2.056	-1.421	-1.126	-1.191	-26.019	-3.402
Free Cash Flow Per Share	-1.048	-1.335	-2.028	-1.363	-1.145	-1.208	-26.074	-3.403

Liquidity Ratios

Year End 31 December 2024	2017	2018	2019	2020	2021	2022	2023	2024
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	16.67M	24.14M	29.08M	47.96M	49.36M	N/A	N/A	N/A

Key Stats and Ratios

Year End 31 December 2024	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	-9322.222	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	-9304.04	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	1.08B
Price to Earnings Ratio	-5.33
Price to Sales Ratio	0
Price to Cash Ratio	12.39
Price to Book Ratio	2.14
Dividend Yield	-

Share Statistics

Shares Outstanding	60.28M
Average Volume (1 week)	417.3k
Average Volume (1 Month)	631.8k
52 Week Change	-53.88%
52 Week High	43.00
52 Week Low	17.24

More Ratios Coming Soon!

Spyre Therapeutics

Kodiak Gas Services

NextEra Energy Partners

Investec Bnk 25

CenterPoint Energy

Vanguard FTSE Emerging M...

Greenbrier Companies

iShares MSCI Taiwan ETF

Spdr S&p 500 Etf

iShares MSCI Australia

Greenland Technologies

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions